Retrospective Study
Copyright ©The Author(s) 2022.
World J Hepatol. Apr 27, 2022; 14(4): 766-777
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.766
Figure 1
Figure 1 Illustrates a flow diagram for study inclusion. STEMI: ST-elevation myocardial infarction-related cardiogenic shock.
Figure 2
Figure 2 This bar chart provides a direct visual comparison of the baseline comorbidities between the two groups. AIDS: Acquired immune deficiency syndrome; CKD: Chronic kidney disease; COPD: Chronic obstructive pulmonary disease; HIV: Human immunodeficiency virus; HLD: Hypomyelinating leukodystrophies; CHF: Chronic heart failure; PVD: Peripheral vascular disease.
Figure 3
Figure 3 This Forrest plot reflects the mortality odds ratios for each intervention for cirrhotic patients with ST-elevation myocardial infarction-related cardiogenic shock. SRCS: ST-elevation myocardial infarction-related cardiogenic shock; PCI: Percutaneous coronary intervention.